Perspectives on Commercialization of Technology Research
To produce value, research and intellectual property (IP) have to be moved into the marketplace through a commercialization path. Learn about the roadblocks and opportunities of transforming promising research into economically viable products and services.
• Gary Keller - CEO of Xomix Ltd.
• Tiffany Wilson - Executive Director of the Global Center for Medical Innovation (GCMI)
• Nicole N. Morris – Director of the TI:GER program and Professor in Practice at Emory
• Kate Havey - Georgia Tech Research Corporation, Technology Licensing
• Arthur F. Spalding - Founder of TAMM Net, Inc.
Early Bird by March 30 Regular and On-Site
LES Member: $20 LES Member: $25
Non-Member: $25 Non-Member: $30
LES Student Member: $10 LES Student Member: $15
No refunds after March 30, 2016. Substitutions are Permitted
Parking: Promenade parking deck can be accessed on either 14th or 15th Street (between Peachtree and West Peachtree); parking will be validated
With Special Thanks to our Sponsor:
Nicole N. Morris is a member of the faculty at Emory University School of Law. She is a Professor in Practice and Director of the TI:GER program. TI:GER (Technological Innovation: Generating Economic Results) is an innovative partnership between Emory and Georgia Institute of Technology (Georgia Tech) that brings together graduate students in law, business, science and engineering to work on ways to take innovative ideas from the lab to the marketplace. As a Professor in Practice, her areas of expertise include patent law, patent litigation, patent prosecution, IP licensing and strategy. Prior to joining the Emory faculty, Professor Morris was the former Managing Patent Counsel at The Coca-Cola Company in Atlanta, Georgia. While at The Coca-Cola Company, she was responsible for the development and implementation of the Company’s global patent strategy. Professor Morris received her B.S. in Chemical Engineering from Northwestern, her M.S. in Chemistry from University of Michigan and her law degree from the University of Minnesota.
Gary N. Keller, MsB, CEO
Gary Keller is CEO of Xomix Ltd., a global technology accelerator and consultancy providing intellectual asset management, commercialization, and global businesses development services. Keller has more than 30 years of experience in international business development for leading biotechnology companies and is responsible for the development, funding and launch of numerous technology and commercialization initiatives and startup companies. He is President and Managing Director of the Midwest University Research Network (MRUN) and Co-Founder and Industry Chairman of H20TECH, a Water Innovation Cluster for the Southeast U.S. He is author of the World Intellectual Property Organization (WIPO) Guide to Commercialization of Intellectual Property and workshops. His startups include NantKwest (NK Nasdaq), a San Diego based biopharma company and the Florida Institute for Commercialization of Public Research. He is an International Delegate and Founder and Chairman Emeritus of the LES USA Canada Emerging Enterprise Committee, and LESI incoming VP Life Sciences
Kate Havey is a Licensing Associate in the Office of Industry engagement of the Georgia Tech Research Corporation, drawing on her experiences from Federal Service and Academia to evaluate incoming invention disclosures for patenting, marketing and licensing opportunities for the purpose of transitioning these important technologies to the public. Ms. Havey holds a BS and MS degrees in Materials Science and Engineering. In 1993, she was commissioned as an officer in the United States Air Force and served subsequent tours as a Research Engineer at the US Air Force Research Laboratory in the Materials Directorate, and an Assistant Professor of Chemistry at the US Air Force Academy in CO Springs. After leaving the USAF, she held a position in University Research Management as the Associate Director of the Particulate Materials Center, an NSF Industry/University Cooperative Research Center, at the Pennsylvania State University.
Tiffany Wilson joined the Global Center for Medical Innovation (GCMI) in 2011 during its startup phase, directing business development activities, building strategic relationships and bringing together core members of the medical device ecosystem. She was quickly promoted to Executive Director, leading all strategic direction and day-to-day operations of the center. Her strong background in medical devices, commitment to fostering innovation and understanding of business strategies have propelled Wilson into a leadership role in the Southeast and brought her into the national spotlight. Wilson joined GCMI from Scientific Intake, where she served as the Vice President of Business Development and Strategy, evaluating marketing and distribution opportunities and driving product development projects for the global obesity market. Prior to Scientific Intake, she was Vice President of Corporate Strategy and Finance at ACell, Inc., a regenerative medicine and tissue engineering company based in Columbia, Maryland. At ACell, Wilson led a broad range of initiatives including corporate finance, investor relations, strategic and operational planning, business development, regulatory, and reimbursement. Wilson earned a BBA in International Business from Loyola University and an MBA from Georgetown University McDonough School of Business.
Arthur Spalding is founder of TAMM Net, Inc., a consultancy servicing biomedical manufacturers. TAMM Net offers the integrated research funding, reimbursement, regulatory, and federal market development solutions biomed firms need to succeed. Mr. Spalding has over 20 years’ experience in pharmaceuticals and medical devices directing various functions including: reimbursement, clinical trial design and facility recruitment, distribution, business development, managed markets, market research, hospital sales, forecasting, and sales operations. Mr. Spalding held management and director level positions at various companies including Parke-Davis, Pfizer, Solvay, Peer-Point Medical Education, and Columbia Laboratories. TAMM Net has helped manufacturers: conduct clinical trials using federal resources; gain reimbursement; gain marketing approvals/clearances; and sell to federal purchasers. Mr. Spalding holds a B.S. in Chemistry from Union College, Schenectady, NY and an MBA in Health Administration from Temple University in Philadelphia.